Silencing c-myc gene by siRNA delivered by cationic niosomes in MCF-7 cells
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Shatha N Abdeljaber und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science, Faculty of Science, Yarmouk University, 21163 Irbid, Jordan. Hauptthemen laut MEDLINE: RNA, Small Interfering, Proto-Oncogene Proteins c-myc, Gene Silencing, Genes, myc. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objectives
Gene therapy has a strong potential to treat different cancer types cancers with high therapeutic outcomes. c-myc is believed to be responsible for more than 15% of all gene regulation and functions as a transcription factor for proteins essential for cell proliferation. This study aimed to develop niosome nanocarriers to knockdown c-myc expression using anti-c-myc short-interfering RNA (siRNA) in MCF-7 cells. Altering the activity of the c-myc proto-oncogene has been identified as an important element in minimizing cancer cell growth because anti-c-myc siRNA degrades c-myc mRNA.
Methods
Noisomes were prepared from Tween 85, cholesterol, and didodecyldimethylammonium bromide at 50:40:10 and 40:40:20 molar ratios. Anti-c-myc siRNA was loaded in the prepared niosomes and then applied on MCF-7 cells. Key findings Niosomes had a total positive charge formed electrostatic interactions with siRNA. Niosomes were spherical with a size range of 70–100 nm. The prepared niosomes were nontoxic to MCF-7 cells, with IC50 values of >250 µg/ml for both formulations. After encapsulation of anti-c-myc siRNA, nioplexes reduced c-myc mRNA expression by more than 50% compared with the untreated cells. Empty niosomes did not affect c-myc mRNA expression levels, indicating that the effect was due to siRNA rather than the particles themselves.
Conclusions
This study provides evidence that niosomes can function as suitable carriers for siRNA delivery to knockdown the c-myc oncogene in MCF-7 cells, thus reducing cancer cell growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science, Faculty of Science, Yarmouk University, 21163 Irbid, Jordan.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, 21163 Irbid, Jordan.
ORCID-Profile: Alaa A Aljabali, Mohammad A Obeid
Zitieren
APA
Abdeljaber, S. N., Aljabali, A. A., Altrad, B., & Obeid, M. A. (2025). Silencing c-myc gene by siRNA delivered by cationic niosomes in MCF-7 cells. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae146
Vancouver
Abdeljaber SN, Aljabali AA, Altrad B, Obeid MA. Silencing c-myc gene by siRNA delivered by cationic niosomes in MCF-7 cells. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae146
BibTeX
@article{Abdeljaber2025,
author = {Abdeljaber, Shatha N and Aljabali, Alaa A and Altrad, Bahaa and Obeid, Mohammad A},
title = {Silencing c-myc gene by siRNA delivered by cationic niosomes in MCF-7 cells},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae146}
}
EUVIMED